J.W. Cole Advisors, Inc. Provention Bio, Inc. Transaction History

J.W. Cole Advisors, Inc.

  • $2.33 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 31, 2022
BUY
$3.43 - $5.62 $1,715 - $2,810
500 Added 3.51%
14,750 $66,000
Q1 2022

Jun 10, 2022
SELL
$3.4 - $7.88 $306,204 - $709,672
-90,060 Reduced 86.34%
14,250 $104,000
Q1 2022

May 16, 2022
BUY
$3.4 - $7.88 $310,454 - $719,522
91,310 Added 702.38%
104,310 $14,000
Q4 2021

Jan 25, 2022
BUY
$5.59 - $7.39 $72,670 - $96,070
13,000 New
13,000 $73,000

Others Institutions Holding PRVB

# of Institutions
1
Shares Held
170K
Call Options Held
0
Put Options Held
0
View Full List

About Provention Bio, Inc.

PRVB Quotes by TradingView
  • Ticker PRVB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 81,549,904
  • Description
  • Provention Bio, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics and solutions to intercept and prevent immune-mediated diseases. Its products candidates include PRV-031 teplizumab and monoclonal antibodies (mAb) that is in Phase III clinical trial for the interception of type one...
More about PRVB
Track This Portfolio

Track J.W. Cole Advisors, Inc. Portfolio

Follow J.W. Cole Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.W. Cole Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on J.W. Cole Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email